2-(4-Methoxyphenyl)-3-methoxybenzoic Acid | 149554-47-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-Methoxyphenyl)-3-methoxybenzoic Acid
• 英文别名: 6,4'-dimethoxy-biphenyl-2-carboxylic acid；3-Methoxy-2-(4-methoxyphenyl)benzoic acid
• CAS: 149554-47-2
• 化学式: C₁₅H₁₄O₄
• 分子量: 258.274
• InChiKey: ZSUGVCFCPLXTJF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(4-Methoxyphenyl)-3-methoxybenzoic Acid 在 PPA 作用下， 反应 3.0h， 生成 2,5-Dimethoxy-9-fluorenone
  参考文献：
  名称：

  Synthesis of substituted fluorenones and substituted 3',3'-dichlorospiro[fluorene-9,2'-thiiranes] and their reactivities

  摘要：

  Several novel 9-fluorenones were synthesized and were used as precursors in an attempt to prepare unique substituted 3',3'-dichlorospiro[fluorene-9,2'-thiiranes]. Several of the thiiranes were unstable and desulfurized during their preparation (7a-d,11,12). 3',3'-Dichloro(2,5-dimethoxyspiro[fluorene-9,2'-thiirane] (7f) was prepared along with 2,2-dichloro-3,3-bis(4-methoxyphenyl)thiirane (16), and 3',3'-dichloro-10,11-dihydrospiro[5H-dibenzo[a,d]cycloheptane-5,2'-thiirane] (17) all of which were stable at room temperature. A study of the reactivity of fluorenyl-substituted thiiranes and other related thiiranes showed that the extent of aromaticity of the substituents at the 3-position of the thiiranes influences their stabilities.

  DOI：

  10.1021/jo00068a039
• 作为产物：
  描述：

  2,3-二甲氧基苯甲酸 在 sodium hydroxide 、 氯化亚砜 、 碘甲烷 作用下， 反应 51.0h， 生成 2-(4-Methoxyphenyl)-3-methoxybenzoic Acid
  参考文献：
  名称：

  Synthesis of substituted fluorenones and substituted 3',3'-dichlorospiro[fluorene-9,2'-thiiranes] and their reactivities

  摘要：

  Several novel 9-fluorenones were synthesized and were used as precursors in an attempt to prepare unique substituted 3',3'-dichlorospiro[fluorene-9,2'-thiiranes]. Several of the thiiranes were unstable and desulfurized during their preparation (7a-d,11,12). 3',3'-Dichloro(2,5-dimethoxyspiro[fluorene-9,2'-thiirane] (7f) was prepared along with 2,2-dichloro-3,3-bis(4-methoxyphenyl)thiirane (16), and 3',3'-dichloro-10,11-dihydrospiro[5H-dibenzo[a,d]cycloheptane-5,2'-thiirane] (17) all of which were stable at room temperature. A study of the reactivity of fluorenyl-substituted thiiranes and other related thiiranes showed that the extent of aromaticity of the substituents at the 3-position of the thiiranes influences their stabilities.

  DOI：

  10.1021/jo00068a039

文献信息

• [EN] SUBSTITUTED QUINOLINE COMPOUNDS<br/>[FR] COMPOSES DE QUINOLINE SUBSTITUES
  申请人：PFIZER PROD INC

  公开号：WO2005080373A1

  公开（公告）日：2005-09-01

  This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.

  本发明涉及式(I)的MTP/Apo-B分泌抑制剂，其中R1-R7、X1、m和n的定义如说明书中所述，以及包含这些化合物的药物组合物，以及这些化合物和组合物的使用方法。本发明的化合物可用于治疗肥胖及其相关疾病、状况或失调。
• Alkyloxyamino substituted fluorenones and their use as protein kinase-C
  申请人：Hoechst Marion Roussel, Inc.

  公开号：US06004959A1

  公开（公告）日：1999-12-21

  The present invention describes certain alkyloxyamino-substituted fluorenones which inhibit protein kinase C, as well as pharmaceutical compositions including these compounds and methods of using these compounds to control protein kinase C activity in mammals, including humans. More specifically, the present compounds are useful for the treatment of neoplastic disease states, disorders associated with abnormal blood flow (including hypertension, ischemia, atherosclerosis, coagulation disorders), and inflammatory diseases (including immune disorders, asthma, lung fibrosis, and psoriasis).

  本发明描述了某些烷氧基氨基取代的氟诺酮，这些化合物抑制蛋白激酶C，以及包括这些化合物的药物组合物和使用这些化合物来控制哺乳动物（包括人类）体内蛋白激酶C活性的方法。更具体地说，目前的化合物可用于治疗肿瘤性疾病状态、与异常血液流动有关的疾病（包括高血压、缺血、动脉粥样硬化、凝血障碍）以及炎症性疾病（包括免疫性疾病、哮喘、肺纤维化和牛皮癣）。
• Amide compounds
  申请人：——

  公开号：US20040157866A1

  公开（公告）日：2004-08-12

  The present invention relates to compounds of the formula (I) wherein X 1 is wherein R 1 , R 2 and R 10 are independently hydrogen or a suitable substituent; R 11 and R 12 are independently hydrogen or a suitable substituent; R is unsaturated 5 to 6-membered heteromonocyclic group; A is direct bond or —NH—; X 2 is monocyclic arylene, unsaturated 5 to 6-membered heteromonocyclic group or cycloalkenylene; Y is bivalent group selected from ethylene, trimethylene and vinylene, wherein CH 2 is optionally replaced by NH or O, and CH is optionally replaced by N; and Z is —(CH 2 ) n —, —CO—(CH 2 ) m —, —CH═CH— or —CO—NH—, wherein n is 1, 2 or 3 and m is 1 or 2, or a salt thereof. The compounds of the present invention inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B. 1

  本发明涉及公式（I）的化合物，其中X1为R1，R2和R10分别为氢原子或适当的取代基；R11和R12分别为氢原子或适当的取代基；R为不饱和的5至6元杂环单环基；A为直接键或—NH—；X2为单环芳烃，不饱和的5至6元杂环单环基或环烯基；Y为乙烯基，三亚甲基或乙烯基中选择的双价基团，其中CH2可以被NH或O替代，CH可以被N替代；Z为—（CH2）n—，—CO—（CH2）m—，—CH=CH—或—CO—NH—，其中n为1、2或3，m为1或2，或其盐。本发明的化合物抑制载脂蛋白B（Apo B）的分泌，并可用作预防和治疗由于Apo B循环水平升高而导致的疾病或病症的药物。
• Substituted quinoline compounds
  申请人：Bertinato Peter

  公开号：US20050234099A1

  公开（公告）日：2005-10-20

  This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R 1 -R 7 , X 1 , m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.

  本发明涉及公式（I）中的MTP / Apo-B分泌抑制剂，其中R1-R7，X1，m和n如规范中所定义，以及包含该化合物的制药组合物，以及该化合物和组合物的使用方法。本发明的化合物在治疗肥胖和相关疾病，状况或障碍方面是有用的。
• TRIAMIDE-SUBSTITUTED HETEROBICYCLIC COMPOUNDS
  申请人：Bertinato Peter

  公开号：US20060223851A1

  公开（公告）日：2006-10-05

  This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R 1 -R 7 , X 1 , m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.

  本发明涉及公式（I）中的MTP / Apo-B分泌抑制剂，其中R1-R7，X1，m和n如规范中定义，以及包含该化合物的制药组合物和该化合物和组合物的使用方法。本发明的化合物在治疗肥胖及其相关疾病，情况或障碍方面有用。